Current Opinion in Pharmacology

Papers
(The H4-Index of Current Opinion in Pharmacology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Metabolic comorbidities of adrenal insufficiency: Focus on steroid replacement therapy and chronopharmacology88
Editorial Board79
Editorial overview: Immune regulation and cancers73
Editorial Board57
Established and novel human translational models to advance cystic fibrosis research, drug discovery, and optimize CFTR-targeting therapeutics57
Routine neoadjuvant chemotherapy for all patients with resectable pancreatic ductal adenocarcinoma? A review of the evidence55
Editorial overview – 2022 respiratory issue: Cystic fibrosis pathophysiology, models, and novel therapies43
Editorial Board42
Editorial Board41
Lipid raft disruption as an opportunity for peripheral analgesia41
Editorial Board36
Non-alcoholic fatty liver disease: Current therapeutic options33
MicroRNA: A mediator of diet-induced cardiovascular protection32
From “contraindicated” to “first line” – Current mechanistic insights beyond canonical β-receptor signaling32
Tropical fruits from Australia as potential treatments for metabolic syndrome31
Dietary serine supplementation: Friend or foe?31
Splice-switching as cancer therapy30
Elexacaftor–tezacaftor–ivacaftor: The new paradigm to treat people with cystic fibrosis with at least one p.Phe508del mutation30
Stress, kisspeptin, and functional hypothalamic amenorrhea29
Shaping DNA damage responses: Therapeutic potential of targeting telomeric proteins and DNA repair factors in cancer29
Pharmacologic treatment of gastroparesis: What is (still) on the horizon?29
New CARs on and off the road: challenges and new developments in CAR-T cell therapy28
Quantitative assessment of volumetric muscle loss: Dual-energy X-ray absorptiometry and ultrasonography28
Organotypic human ex vivo models for coronavirus disease 2019 research and drug development28
Host membrane proteins in the HIV-induced membrane fusion: Role in pathogenesis and therapeutic potential of autoantibodies27
Current pharmacological treatment of hepatocellular carcinoma27
0.089010953903198